Atlas Trials

Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection

Clinical trial NCT01767415 · COMPLETED

Trial details

NCT number
NCT01767415
Sponsor
Weill Medical College of Cornell University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Brain Tumors With Ill-defined Margins
Start date
2012-04-01
Primary completion
2014-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.